{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:55:24Z","timestamp":1792184124241,"version":"4.4.0"},"reference-count":20,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2025,8,22]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Evidence for atrial shunt devices in heart failure with reduced ejection fraction (HFrEF) is limited. This study aimed to evaluate the 1-year clinical and haemodynamic outcomes associated with an atrial shunt device in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective, multicentre, single-arm cohort study of an interatrial shunt in heart failure with reduced ejection fraction (SUSTAIN-HF), 120 symptomatic HFrEF patients (left ventricular ejection fraction; LVEF \u226440%) on guideline-directed medical therapy were enrolled across 16 centres in China. The intervention was implantation of the D-Shant atrial shunt device. Prespecified primary outcomes were the changes from baseline to 1 year in 6\u2009min walk distance (6MWD) and New York Heart Association (NYHA) functional class. Secondary outcomes included quality of life (Kansas City Cardiomyopathy Questionnaire; KCCQ), echocardiographic parameters and adjudicated adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between October 2017 and December 2021, 120 patients were enrolled. At 1-year follow-up, implantation of the shunt device was associated with significant improvements in clinical outcomes. The mean 6MWD increased by 54.1 m (95%\u2009CI 45.9 to 62.3; p&lt;0.0001), and the KCCQ overall score was improved by 16.5 points (95%\u2009CI 13.9 to 19.1; p&lt;0.0001). The proportion of patients in NYHA class III\/IV decreased from 95.0% to 22.9% (p&lt;0.0001). The annualised rate of heart failure hospitalisation was reduced from 3.3 to 0.3 events per patient-year (p&lt;0.0001). LVEF increased by 9.0% (95% CI 6.9% to 11.1%; p&lt;0.0001). The primary safety endpoint, a composite of major adverse cardiac and device-related events at 1 year, occurred in 15.0% of patients, driven primarily by cardiovascular death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this prospective cohort study of symptomatic HFrEF patients, treatment with the D-Shant atrial shunt device was associated with significant improvements in functional capacity, quality of life and rates of heart failure hospitalisation at 1 year. The single-arm design precludes definitive conclusions on treatment efficacy, underscoring the need for randomised, sham-controlled trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/heartjnl-2025-326319","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:10:20Z","timestamp":1760699420000},"page":"624-629","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Prospective multicentre single-arm study of an interatrial shunt in heart failure with reduced ejection fraction (SUSTAIN-HF): 1-year clinical and haemodynamic outcomes"],"prefix":"10.1136","volume":"112","author":[{"given":"Changdong","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Surgery, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaozhen","family":"Li","sequence":"additional","affiliation":[{"name":"Echocardiography Room of Heart Center, Wuhan Children's Hospital\uff08Wuhan Maternal and Child Healthcare Hospital),Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyuan","family":"Song","sequence":"additional","affiliation":[{"name":"Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, The First Affiliated Hospital of Air Force Medical University, Xi\u2019an, Shananxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Second Affiliated Hospital of Air Force Medical University, Xi\u2019an, Shananxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Guangxi Zhuang Autonomous Region People\u2019s Hospital, Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[{"name":"Hubei University of Technology, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyu","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoke","family":"Shang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5080-4523","authenticated-orcid":false,"given":"Nianguo","family":"Dong","sequence":"additional","affiliation":[{"name":"Union Hospital, Tongji Medical College, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"2026051306501316000_112.11.624.1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.059486"},{"key":"2026051306501316000_112.11.624.2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ahj.2023.05.022","article-title":"Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation","volume":"264","author":"Kar","year":"2023","journal-title":"Am Heart J"},{"key":"2026051306501316000_112.11.624.3","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0140-6736(22)00016-2","article-title":"Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial","volume":"399","author":"Shah","year":"2022","journal-title":"The Lancet"},{"key":"2026051306501316000_112.11.624.4","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1161\/CIRCULATIONAHA.124.070870","article-title":"Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial","volume":"150","author":"Stone","year":"2024","journal-title":"Circulation"},{"key":"2026051306501316000_112.11.624.5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.amjcard.2024.06.023","article-title":"Design and Rationale of the V-Wave Shunt MitraClip Study","volume":"227","author":"Reed","year":"2024","journal-title":"Am J Cardiol"},{"key":"2026051306501316000_112.11.624.6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"2026051306501316000_112.11.624.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1511175"},{"key":"2026051306501316000_112.11.624.8","doi-asserted-by":"crossref","first-page":"17058","DOI":"10.1038\/nrdp.2017.58","article-title":"Heart failure with reduced ejection fraction","volume":"3","author":"Bloom","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"2026051306501316000_112.11.624.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2022.02.010"},{"key":"2026051306501316000_112.11.624.10","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10091803","article-title":"Medical Therapy of Heart Failure with Reduced Ejection Fraction-A Call for Comparative Research","volume":"10","author":"Cotter","year":"2021","journal-title":"J Clin Med"},{"key":"2026051306501316000_112.11.624.11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003662","article-title":"One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection Fraction","volume":"9","author":"Kaye","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026051306501316000_112.11.624.12","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2025-325929"},{"key":"2026051306501316000_112.11.624.13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41569-023-00923-w","article-title":"Interatrial shunt devices for heart failure","volume":"20","author":"Gustafsson","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"2026051306501316000_112.11.624.14","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/ehf2.13842","article-title":"Clinical study on the treatment of chronic heart failure with a novel D-shant atrium shunt device","volume":"9","author":"Shang","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026051306501316000_112.11.624.15","doi-asserted-by":"crossref","first-page":"1121689","DOI":"10.3389\/fcvm.2023.1121689","article-title":"Biventricular longitudinal strain as a predictor of functional improvement after D-shant device implantation in patients with heart failure","volume":"10","author":"Zhou","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2026051306501316000_112.11.624.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00531-3"},{"key":"2026051306501316000_112.11.624.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.12.010"},{"key":"2026051306501316000_112.11.624.18","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/ejhf.3215","article-title":"Interatrial shunt therapy in advanced heart failure: Outcomes from the open-label cohort of the RELIEVE-HF trial","volume":"26","author":"Rod\u00e9s-Cabau","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026051306501316000_112.11.624.19","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.478"},{"key":"2026051306501316000_112.11.624.20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2025.03.474","article-title":"AS-1325 Impact of Atrial Shunt Device on Prognosis and Risk Factors in Heart Failure With Reduced Ejection Fraction (SUSTAIN-HF): A National, Multicenter, Phase III, Single Group Clinical Study","volume":"85","author":"Zhang","year":"2025","journal-title":"J Am Coll Cardiol"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2025-326319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:50:35Z","timestamp":1778680235000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2025-326319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":20,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,5,12]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/heartjnl-2025-326319"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2025-326319","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]}}}